Jin Medical International Ltd. (ZJYL)

2.34USD -0.43% (-0.01)

Over 1M: +18.2%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

2 2.5 3 3.5
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Annual

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
FY21 — Revenue: 20.8M FY21 — Operating Cash Flow: 5.8M FY21 — Net Income: 2.6M FY22 — Revenue: 19.2M FY22 — Operating Cash Flow: 1.6M FY22 — Net Income: 2.7M FY23 — Revenue: 19.8M FY23 — Operating Cash Flow: 3.1M FY23 — Net Income: 2.9M FY24 — Revenue: 23.5M FY24 — Operating Cash Flow: -1.2M FY24 — Net Income: 3.7M FY25 — Revenue: 20.7M FY25 — Operating Cash Flow: 2.9M FY25 — Net Income: 1.2M 0 5M 10M 15M 20M 25M
FY21 FY22 FY23 FY24 FY25
Revenue Operating Cash Flow Net Income

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

5.2
ROIC 5662.5%
SBC / sales 0.0%
Adj. EBITDA margin 4.1%
Oper. margin 2.9%
OE margin -18.0%
Accruals -3.2%
OCF / EBIT 4.8×
OCF margin 14.0%
Profit margin 5.8%
ROA 2.2%
Asset turnover 0.39×
EBITDA margin 4.1%
Gross margin 29.2%
ROCE 2.1%
ROE 4.0%
Capex / sales 32.0%
FCF margin -18.0%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.8
EV/EBIT 484.1×
EV/OE -79.0×
P/C 10.9×
EV/GP 48.7×
EV/Sales 14.2×
FCF yield -1.1%
P/B 10.9×
P/E 272.0×
Div. yield —
Fwd P/E —
PEG —
Shareholder yield —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.2
Revenue growth in the worst year on record -12.0%
Gross margin stability across years 3.9 pp
RPO / sales 0.024×
Cash-flow margin stability 10.8 pp
Prepaid revenue growth -26.2%
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

5.3
ND/EBITDA 0.1
Current ratio 1.9×
Interest cover 1.5×
Debt / Eq 0.0×
Debt payback 0.0 yr
Net debt / Eq 0.0×
Payout 0.0%
Cash runway 8.0 yr
Equity / Assets 55.5%
Quick ratio 1.6×
F-score 3.4 pts
Cash / Debt —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales CAGR 4Y -0.093%
Most recent margin move -14.6
Operating margin trend -2.4
Sales/sh Y/Y -12.0%
Shares change +0.047%
EBIT CAGR -30.7%
EBIT Y/Y -83.3%
EPS Y/Y -67.6%
Gross profit Y/Y -36.4%
Div. growth —
EPS CAGR 4Y —
EPS next Y —
Sales Q/Q —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.